Daudi（人Burkitt淋巴瘤細胞）
CBP60262
詢 價
索取STR
產品描述
產品數據庫
| I. General information | |
| Synonyms: | Daudi |
| Background: | The Daudi line was derived from a 16-year-old Black male with Burkitt's lymphoma by E. Klein and G. Klein in May, 1967. |
| Species: | Homo sapiens, human |
| Tissue: | peripheral blood |
| Disease: | Burkitt's lymphoma |
| Gender: | male, 16 years, Black |
| Morphology: | lymphoblast |
| Growth Mode: | suspension |
| DNA Profile: | Amelogenin: X,Y CSF1PO: 12 D13S317: 11,12 D16S539: 10,12 D5S818: 8,13 D7S820: 8,10 THO1: 6,7 TPOX: 8,11 vWA: 15,17 Cobioer’s Cell Line Authentication Service |
| Culture Medium: |
RPMI-1640+10%FBS Daudi完全培養(yǎng)基，# CBP60262M |
| Cryopreservation medium: | 90%FBS+10%DMSO |
| Receptor Expression: | complement, expressed Fc, expressed |
| Tumor Formation: | Yes, in nude mice; forms colonies in agarose |
| Comments: | The cells are negative for beta-2-microglobulin. They are positive for EBNA, VCA and Surface immunoglobulin (sIg+). ATCC confirmed this cell line is positive for the presence of EBV viral DNA sequences via PCR. For more information, please contact Cobioer (4008-750-250). |
